Global Treatment for Communicable Diseases Market Research Report 2022
SKU ID : QYR-21176436 | Publishing Date : 29-Jun-2022
Detailed TOC of Global Treatment for Communicable Diseases Market Research Report 2022
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Treatment for Communicable Diseases Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 HIV
1.2.3 Influenza
1.2.4 TB
1.2.5 Malaria
1.2.6 Hepatitis
1.2.7 HPV
1.3 Market by Application
1.3.1 Global Treatment for Communicable Diseases Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Treatment for Communicable Diseases Market Perspective (2017-2028)
2.2 Treatment for Communicable Diseases Growth Trends by Region
2.2.1 Treatment for Communicable Diseases Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Treatment for Communicable Diseases Historic Market Size by Region (2017-2022)
2.2.3 Treatment for Communicable Diseases Forecasted Market Size by Region (2023-2028)
2.3 Treatment for Communicable Diseases Market Dynamics
2.3.1 Treatment for Communicable Diseases Industry Trends
2.3.2 Treatment for Communicable Diseases Market Drivers
2.3.3 Treatment for Communicable Diseases Market Challenges
2.3.4 Treatment for Communicable Diseases Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Treatment for Communicable Diseases Players by Revenue
3.1.1 Global Top Treatment for Communicable Diseases Players by Revenue (2017-2022)
3.1.2 Global Treatment for Communicable Diseases Revenue Market Share by Players (2017-2022)
3.2 Global Treatment for Communicable Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Treatment for Communicable Diseases Revenue
3.4 Global Treatment for Communicable Diseases Market Concentration Ratio
3.4.1 Global Treatment for Communicable Diseases Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Treatment for Communicable Diseases Revenue in 2021
3.5 Treatment for Communicable Diseases Key Players Head office and Area Served
3.6 Key Players Treatment for Communicable Diseases Product Solution and Service
3.7 Date of Enter into Treatment for Communicable Diseases Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Treatment for Communicable Diseases Breakdown Data by Type
4.1 Global Treatment for Communicable Diseases Historic Market Size by Type (2017-2022)
4.2 Global Treatment for Communicable Diseases Forecasted Market Size by Type (2023-2028)
5 Treatment for Communicable Diseases Breakdown Data by Application
5.1 Global Treatment for Communicable Diseases Historic Market Size by Application (2017-2022)
5.2 Global Treatment for Communicable Diseases Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Treatment for Communicable Diseases Market Size (2017-2028)
6.2 North America Treatment for Communicable Diseases Market Size by Country (2017-2022)
6.3 North America Treatment for Communicable Diseases Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Treatment for Communicable Diseases Market Size (2017-2028)
7.2 Europe Treatment for Communicable Diseases Market Size by Country (2017-2022)
7.3 Europe Treatment for Communicable Diseases Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Treatment for Communicable Diseases Market Size (2017-2028)
8.2 Asia-Pacific Treatment for Communicable Diseases Market Size by Country (2017-2022)
8.3 Asia-Pacific Treatment for Communicable Diseases Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Treatment for Communicable Diseases Market Size (2017-2028)
9.2 Latin America Treatment for Communicable Diseases Market Size by Country (2017-2022)
9.3 Latin America Treatment for Communicable Diseases Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Treatment for Communicable Diseases Market Size (2017-2028)
10.2 Middle East & Africa Treatment for Communicable Diseases Market Size by Country (2017-2022)
10.3 Middle East & Africa Treatment for Communicable Diseases Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis Treatment for Communicable Diseases Introduction
11.1.4 Novartis Revenue in Treatment for Communicable Diseases Business (2017-2022)
11.1.5 Novartis Recent Development
11.2 Gilead
11.2.1 Gilead Company Detail
11.2.2 Gilead Business Overview
11.2.3 Gilead Treatment for Communicable Diseases Introduction
11.2.4 Gilead Revenue in Treatment for Communicable Diseases Business (2017-2022)
11.2.5 Gilead Recent Development
11.3 GSK
11.3.1 GSK Company Detail
11.3.2 GSK Business Overview
11.3.3 GSK Treatment for Communicable Diseases Introduction
11.3.4 GSK Revenue in Treatment for Communicable Diseases Business (2017-2022)
11.3.5 GSK Recent Development
11.4 Janssen Pharmaceutical
11.4.1 Janssen Pharmaceutical Company Detail
11.4.2 Janssen Pharmaceutical Business Overview
11.4.3 Janssen Pharmaceutical Treatment for Communicable Diseases Introduction
11.4.4 Janssen Pharmaceutical Revenue in Treatment for Communicable Diseases Business (2017-2022)
11.4.5 Janssen Pharmaceutical Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Treatment for Communicable Diseases Introduction
11.5.4 Roche Revenue in Treatment for Communicable Diseases Business (2017-2022)
11.5.5 Roche Recent Development
11.6 BioCryst Pharmaceuticals
11.6.1 BioCryst Pharmaceuticals Company Detail
11.6.2 BioCryst Pharmaceuticals Business Overview
11.6.3 BioCryst Pharmaceuticals Treatment for Communicable Diseases Introduction
11.6.4 BioCryst Pharmaceuticals Revenue in Treatment for Communicable Diseases Business (2017-2022)
11.6.5 BioCryst Pharmaceuticals Recent Development
11.7 Merck
11.7.1 Merck Company Detail
11.7.2 Merck Business Overview
11.7.3 Merck Treatment for Communicable Diseases Introduction
11.7.4 Merck Revenue in Treatment for Communicable Diseases Business (2017-2022)
11.7.5 Merck Recent Development
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Detail
11.8.2 Boehringer Ingelheim Business Overview
11.8.3 Boehringer Ingelheim Treatment for Communicable Diseases Introduction
11.8.4 Boehringer Ingelheim Revenue in Treatment for Communicable Diseases Business (2017-2022)
11.8.5 Boehringer Ingelheim Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Treatment for Communicable Diseases Market Research Report 2022
List of TablesTable 1. Global Treatment for Communicable Diseases Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of HIV
Table 3. Key Players of Influenza
Table 4. Key Players of TB
Table 5. Key Players of Malaria
Table 6. Key Players of Hepatitis
Table 7. Key Players of HPV
Table 8. Global Treatment for Communicable Diseases Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Treatment for Communicable Diseases Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 10. Global Treatment for Communicable Diseases Market Size by Region (2017-2022) & (US$ Million)
Table 11. Global Treatment for Communicable Diseases Market Share by Region (2017-2022)
Table 12. Global Treatment for Communicable Diseases Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 13. Global Treatment for Communicable Diseases Market Share by Region (2023-2028)
Table 14. Treatment for Communicable Diseases Market Trends
Table 15. Treatment for Communicable Diseases Market Drivers
Table 16. Treatment for Communicable Diseases Market Challenges
Table 17. Treatment for Communicable Diseases Market Restraints
Table 18. Global Treatment for Communicable Diseases Revenue by Players (2017-2022) & (US$ Million)
Table 19. Global Treatment for Communicable Diseases Market Share by Players (2017-2022)
Table 20. Global Top Treatment for Communicable Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Treatment for Communicable Diseases as of 2021)
Table 21. Ranking of Global Top Treatment for Communicable Diseases Companies by Revenue (US$ Million) in 2021
Table 22. Global 5 Largest Players Market Share by Treatment for Communicable Diseases Revenue (CR5 and HHI) & (2017-2022)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Treatment for Communicable Diseases Product Solution and Service
Table 25. Date of Enter into Treatment for Communicable Diseases Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Treatment for Communicable Diseases Market Size by Type (2017-2022) & (US$ Million)
Table 28. Global Treatment for Communicable Diseases Revenue Market Share by Type (2017-2022)
Table 29. Global Treatment for Communicable Diseases Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 30. Global Treatment for Communicable Diseases Revenue Market Share by Type (2023-2028)
Table 31. Global Treatment for Communicable Diseases Market Size by Application (2017-2022) & (US$ Million)
Table 32. Global Treatment for Communicable Diseases Revenue Market Share by Application (2017-2022)
Table 33. Global Treatment for Communicable Diseases Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 34. Global Treatment for Communicable Diseases Revenue Market Share by Application (2023-2028)
Table 35. North America Treatment for Communicable Diseases Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Treatment for Communicable Diseases Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Treatment for Communicable Diseases Market Size by Country (2017-2022) & (US$ Million)
Table 38. Europe Treatment for Communicable Diseases Market Size by Country (2023-2028) & (US$ Million)
Table 39. Asia-Pacific Treatment for Communicable Diseases Market Size by Region (2017-2022) & (US$ Million)
Table 40. Asia-Pacific Treatment for Communicable Diseases Market Size by Region (2023-2028) & (US$ Million)
Table 41. Latin America Treatment for Communicable Diseases Market Size by Country (2017-2022) & (US$ Million)
Table 42. Latin America Treatment for Communicable Diseases Market Size by Country (2023-2028) & (US$ Million)
Table 43. Middle East & Africa Treatment for Communicable Diseases Market Size by Country (2017-2022) & (US$ Million)
Table 44. Middle East & Africa Treatment for Communicable Diseases Market Size by Country (2023-2028) & (US$ Million)
Table 45. Novartis Company Detail
Table 46. Novartis Business Overview
Table 47. Novartis Treatment for Communicable Diseases Product
Table 48. Novartis Revenue in Treatment for Communicable Diseases Business (2017-2022) & (US$ Million)
Table 49. Novartis Recent Development
Table 50. Gilead Company Detail
Table 51. Gilead Business Overview
Table 52. Gilead Treatment for Communicable Diseases Product
Table 53. Gilead Revenue in Treatment for Communicable Diseases Business (2017-2022) & (US$ Million)
Table 54. Gilead Recent Development
Table 55. GSK Company Detail
Table 56. GSK Business Overview
Table 57. GSK Treatment for Communicable Diseases Product
Table 58. GSK Revenue in Treatment for Communicable Diseases Business (2017-2022) & (US$ Million)
Table 59. GSK Recent Development
Table 60. Janssen Pharmaceutical Company Detail
Table 61. Janssen Pharmaceutical Business Overview
Table 62. Janssen Pharmaceutical Treatment for Communicable Diseases Product
Table 63. Janssen Pharmaceutical Revenue in Treatment for Communicable Diseases Business (2017-2022) & (US$ Million)
Table 64. Janssen Pharmaceutical Recent Development
Table 65. Roche Company Detail
Table 66. Roche Business Overview
Table 67. Roche Treatment for Communicable Diseases Product
Table 68. Roche Revenue in Treatment for Communicable Diseases Business (2017-2022) & (US$ Million)
Table 69. Roche Recent Development
Table 70. BioCryst Pharmaceuticals Company Detail
Table 71. BioCryst Pharmaceuticals Business Overview
Table 72. BioCryst Pharmaceuticals Treatment for Communicable Diseases Product
Table 73. BioCryst Pharmaceuticals Revenue in Treatment for Communicable Diseases Business (2017-2022) & (US$ Million)
Table 74. BioCryst Pharmaceuticals Recent Development
Table 75. Merck Company Detail
Table 76. Merck Business Overview
Table 77. Merck Treatment for Communicable Diseases Product
Table 78. Merck Revenue in Treatment for Communicable Diseases Business (2017-2022) & (US$ Million)
Table 79. Merck Recent Development
Table 80. Boehringer Ingelheim Company Detail
Table 81. Boehringer Ingelheim Business Overview
Table 82. Boehringer Ingelheim Treatment for Communicable Diseases Product
Table 83. Boehringer Ingelheim Revenue in Treatment for Communicable Diseases Business (2017-2022) & (US$ Million)
Table 84. Boehringer Ingelheim Recent Development
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Treatment for Communicable Diseases Market Share by Type: 2021 VS 2028
Figure 2. HIV Features
Figure 3. Influenza Features
Figure 4. TB Features
Figure 5. Malaria Features
Figure 6. Hepatitis Features
Figure 7. HPV Features
Figure 8. Global Treatment for Communicable Diseases Market Share by Application in 2021 & 2028
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Other Case Studies
Figure 12. Treatment for Communicable Diseases Report Years Considered
Figure 13. Global Treatment for Communicable Diseases Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 14. Global Treatment for Communicable Diseases Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Treatment for Communicable Diseases Market Share by Region: 2021 VS 2028
Figure 16. Global Treatment for Communicable Diseases Market Share by Players in 2021
Figure 17. Global Top Treatment for Communicable Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Treatment for Communicable Diseases as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Treatment for Communicable Diseases Revenue in 2021
Figure 19. North America Treatment for Communicable Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. North America Treatment for Communicable Diseases Market Share by Country (2017-2028)
Figure 21. United States Treatment for Communicable Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Treatment for Communicable Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Treatment for Communicable Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Treatment for Communicable Diseases Market Share by Country (2017-2028)
Figure 25. Germany Treatment for Communicable Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Treatment for Communicable Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Treatment for Communicable Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Treatment for Communicable Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Treatment for Communicable Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Treatment for Communicable Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Treatment for Communicable Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Treatment for Communicable Diseases Market Share by Region (2017-2028)
Figure 33. China Treatment for Communicable Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Japan Treatment for Communicable Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. South Korea Treatment for Communicable Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Southeast Asia Treatment for Communicable Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. India Treatment for Communicable Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Australia Treatment for Communicable Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America Treatment for Communicable Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Latin America Treatment for Communicable Diseases Market Share by Country (2017-2028)
Figure 41. Mexico Treatment for Communicable Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Brazil Treatment for Communicable Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa Treatment for Communicable Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Middle East & Africa Treatment for Communicable Diseases Market Share by Country (2017-2028)
Figure 45. Turkey Treatment for Communicable Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Saudi Arabia Treatment for Communicable Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Novartis Revenue Growth Rate in Treatment for Communicable Diseases Business (2017-2022)
Figure 48. Gilead Revenue Growth Rate in Treatment for Communicable Diseases Business (2017-2022)
Figure 49. GSK Revenue Growth Rate in Treatment for Communicable Diseases Business (2017-2022)
Figure 50. Janssen Pharmaceutical Revenue Growth Rate in Treatment for Communicable Diseases Business (2017-2022)
Figure 51. Roche Revenue Growth Rate in Treatment for Communicable Diseases Business (2017-2022)
Figure 52. BioCryst Pharmaceuticals Revenue Growth Rate in Treatment for Communicable Diseases Business (2017-2022)
Figure 53. Merck Revenue Growth Rate in Treatment for Communicable Diseases Business (2017-2022)
Figure 54. Boehringer Ingelheim Revenue Growth Rate in Treatment for Communicable Diseases Business (2017-2022)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Keyplayers in Global Treatment for Communicable Diseases Market Research Report 2022
NovartisGilead
GSK
Janssen Pharmaceutical
Roche
BioCryst Pharmaceuticals
Merck
Boehringer Ingelheim